NASDAQ:SIEN - Sientra Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
About
FAQ

Consensus Rating: Buy
Consensus Price Target: $9.75
Forecasted Upside: 30.30 %
Number of Analysts: 4
Breakdown:
0 Sell Ratings
0 Hold Ratings
4 Buy Ratings
0 Strong Buy Ratings

^$7.48 As of 07/23/2021 01:00 AM ET

▼ -0.12 (-1.58%)

1 month | 3 months | 12 months

Get New Sientra Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for SIEN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SIEN

^$9.75

▲ +30.30% Upside Potential

This price target is based on 4 analysts offering 12 month price targets for Sientra in the last 3 months. The average price target is $9.75, with a high forecast of $11.00 and a low forecast of $8.24. The average price target represents a 30.30% upside from the last price of $7.48.

Current Consensus is Buy

The current consensus among 4 polled investment analysts is to buy stock in Sientra. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations Description Skip Past Price Target Consensus Chart

0 strong buy ratings
8 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

1/30/2020

0 strong buy ratings
7 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

4/29/2020

0 strong buy ratings
6 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

7/28/2020

0 strong buy ratings
6 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

10/26/2020

0 strong buy ratings
6 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

1/24/2021

0 strong buy ratings
4 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

4/24/2021

0 strong buy ratings
4 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

6/23/2021

0 strong buy ratings
4 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

7/23/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
7/14/2021	SVB Leerink	Set Price Target	Buy	$8.24	Low
5/18/2021	Canaccord Genuity	Boost Price Target	Buy	$9.00 ➝ $10.00	N/A
5/12/2021	SVB Leerink	Boost Price Target	Outperform	$10.00 ➝ $11.00	High
5/12/2021	Canaccord Genuity	Reiterated Rating	Buy	$9.00 ➝ $10.00	High
3/12/2021	Canaccord Genuity	Boost Price Target	Buy	$8.00 ➝ $9.00	Medium
3/12/2021	SVB Leerink	Boost Price Target	Outperform	$8.00 ➝ $10.00	High
2/5/2021	Maxim Group	Reiterated Rating	Buy	$11.00	High
2/5/2021	Canaccord Genuity	Boost Price Target	Buy	$6.00 ➝ $8.00	High
11/10/2020	William Blair	Reiterated Rating	Outperform		Low
11/10/2020	SVB Leerink	Boost Price Target	Outperform	$6.00 ➝ $8.00	High
8/14/2020	Canaccord Genuity	Reiterated Rating	Buy	$6.00	High
8/12/2020	Maxim Group	Reiterated Rating	Buy	$8.00	High
8/11/2020	SVB Leerink	Boost Price Target	Outperform	$5.30 ➝ $6.00	High
6/11/2020	Maxim Group	Boost Price Target		$5.00 ➝ $8.00	Low
5/15/2020	Canaccord Genuity	Lower Price Target	Buy	$9.00 ➝ $5.00	Medium
5/12/2020	SVB Leerink	Lower Price Target	Outperform	$6.50 ➝ $5.30	High
3/23/2020	Stephens	Lower Price Target	Overweight	$10.00 ➝ $5.00	High
3/12/2020	Craig Hallum	Lower Price Target	Buy	$14.00 ➝ $9.00	High
3/12/2020	SVB Leerink	Lower Price Target	Outperform	$13.00 ➝ $6.50	High
3/12/2020	Canaccord Genuity	Lower Price Target	Buy	$13.00 ➝ $9.00	High
3/12/2020	Maxim Group	Lower Price Target	Buy	$12.00 ➝ $8.00	High
3/12/2020	Stephens	Lower Price Target	Overweight	$14.00 ➝ $10.00	High
11/5/2019	William Blair	Upgrade	Market Perform ➝ Outperform		Medium
9/24/2019	Canaccord Genuity	Set Price Target	Buy	$13.00	High
8/9/2019	Stephens	Set Price Target	Buy	$16.00	Low
8/9/2019	Canaccord Genuity	Boost Price Target	Buy	$11.00 ➝ $13.00	N/A
8/9/2019	Maxim Group	Reiterated Rating	Buy ➝ Buy	$16.00 ➝ $12.00	High
7/25/2019	Craig Hallum	Lower Price Target	Buy	$20.00 ➝ $14.00	Medium
6/5/2019	Wells Fargo & Company	Upgrade	Market Perform ➝ Outperform	$8.00 ➝ $10.00	High
4/22/2019	Craig Hallum	Set Price Target	Buy	$23.00	Low
3/26/2019	Craig Hallum	Set Price Target	Buy	$23.00	High
3/14/2019	Wells Fargo & Company	Initiated Coverage	Market Perform	$9.00	High
3/13/2019	Stifel Nicolaus	Lower Price Target	Buy	$19.00 ➝ $16.00	Medium
3/13/2019	Dougherty & Co	Lower Price Target	Buy	$29.00 ➝ $27.00	High
3/13/2019	SVB Leerink	Lower Price Target		$22.00 ➝ $18.00	High
3/13/2019	William Blair	Downgrade	Outperform ➝ Market Perform		High
2/11/2019	Maxim Group	Reiterated Rating	Buy	$20.00	Medium
12/19/2018	Maxim Group	Upgrade	Hold ➝ Buy		Low
8/30/2018	Dougherty & Co	Initiated Coverage	Buy ➝ Buy	$31.00	Medium
8/9/2018	Stephens	Reiterated Rating	Buy	$30.00	High
8/8/2018	Stifel Nicolaus	Boost Price Target	Buy ➝ Buy	$21.00 ➝ $25.00	High
8/8/2018	Canaccord Genuity	Boost Price Target	Buy	$19.00 ➝ $25.00	High
6/4/2018	Craig Hallum	Initiated Coverage	Buy	$23.00	High
5/10/2018	Canaccord Genuity	Reiterated Rating	Buy	$19.00	High
4/27/2018	Lake Street Capital	Upgrade	Hold ➝ Buy	$16.00	Low
4/26/2018	Maxim Group	Boost Price Target	Buy ➝ Buy	$15.00 ➝ $19.00	Low
4/20/2018	SVB Leerink	Reiterated Rating	Outperform		High
4/19/2018	Canaccord Genuity	Reiterated Rating	Buy	$18.00	High
4/19/2018	Lake Street Capital	Boost Price Target	Hold ➝ Hold	$11.00 ➝ $13.00	High
3/22/2018	Maxim Group	Initiated Coverage	Buy ➝ Buy	$15.00	High
3/14/2018	Canaccord Genuity	Lower Price Target	Buy ➝ Buy	$19.00 ➝ $18.00	Low
3/1/2018	William Blair	Reiterated Rating	Buy		Low
2/21/2018	Lake Street Capital	Downgrade	Buy ➝ Hold	$15.00 ➝ $11.00	High
1/19/2018	Stifel Nicolaus	Upgrade	Hold ➝ Buy	$14.00	High
1/5/2018	Canaccord Genuity	Reiterated Rating	Buy	$19.00	High
10/8/2017	Canaccord Genuity	Reiterated Rating	Buy	$14.00	N/A
9/27/2017	Stifel Nicolaus	Reiterated Rating	Hold ➝ Hold	$11.00 ➝ $14.00	High
9/13/2017	William Blair	Upgrade	Market Perform ➝ Outperform		High
8/28/2017	Canaccord Genuity	Initiated Coverage	Buy ➝ Buy	$14.00	High
8/8/2017	Lake Street Capital	Reiterated Rating	Buy	$11.00 ➝ $15.00	Low
8/2/2017	Lake Street Capital	Reiterated Rating	Buy ➝ Buy	$11.00 ➝ $15.00	High
7/11/2017	Stephens	Initiated Coverage	Overweight	$12.00	High
4/17/2017	Lake Street Capital	Initiated Coverage	Buy ➝ Buy	$11.00	High
8/10/2016	William Blair	Reiterated Rating	Market Perform		N/A

(Data available from 7/24/2016 forward)

Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States and internationally. It operates through two segments, Breast Products and miraDry. The company offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. It also provides body contouring products; facial and nasal implants; saline filled breast implant sizers; and miraDry System, a non-surgical device for the permanent reduction of underarm sweat, odor, and hair of all colors. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Santa Barbara, California.

Today's Range

Now: $7.48

$7.32

$7.89

50 Day Range

MA: $7.45

$6.86

$8.53

52 Week Range

Now: $7.48

$3.21

$9.14

Volume

260,010 shs

Average Volume

959,052 shs

Market Capitalization

$430.26 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.15

Frequently Asked Questions

What sell-side analysts currently cover shares of Sientra?

The following Wall Street sell-side analysts have issued research reports on Sientra in the last year: Canaccord Genuity, Maxim Group, SVB Leerink LLC, William Blair, and Zacks Investment Research.
View the latest analyst ratings for SIEN.

What is the current price target for Sientra?

3 Wall Street analysts have set twelve-month price targets for Sientra in the last year. Their average twelve-month price target is $9.75, suggesting a possible upside of 32.2%. Maxim Group has the highest price target set, predicting SIEN will reach $11.00 in the next twelve months. SVB Leerink LLC has the lowest price target set, forecasting a price of $8.24 for Sientra in the next year.
View the latest price targets for SIEN.

What is the current consensus analyst rating for Sientra?

Sientra currently has 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe SIEN will outperform the market and that investors should add to their positions of Sientra.
View the latest ratings for SIEN.

What other companies compete with Sientra?

Other companies that are similar to Sientra include Avanos Medical, Inogen, Eargo, Sanara MedTech, Invacare, Conformis, United Health Products, Lakeland Industries, Alpha Pro Tech, Surgalign, Milestone Scientific, CollPlant Biotechnologies, Nutriband, Predictive Oncology and ReWalk Robotics.

How do I contact Sientra's investor relations team?

Sientra's physical mailing address is 420 SOUTH FAIRVIEW AVENUE SUITE 200, SANTA BARBARA CA, 93117. The medical instruments supplier's listed phone number is 805-562-3500 and its investor relations email address is [email protected] The official website for Sientra is www.sientra.com.